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Overview of Reproductive and
Developmental Toxicity Studies of
1,3-Butadiene in Rodents
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Patricia L. Hackett,t Melvin R. Sikov,t Bryan D.
Hardin,* Beatrice J. McClanahan,t John R. Decker,t
and Terryl J. Mastt
Aseriesofstudiestofurtherevaluate thedevelopmental andreproductivetoxicityofinhaled1,3-butadiene
wassponsoredbytheNationalToxicologyProgram. PregnantSprague-Dawleyrats(24-28/group) andSwiss
(CD-1) mice (18-22/group) were exposed to atmospheric concentrations of 0, 40, 200, or 1000 ppm 1,3-
butadiene for 6 hr/day on days 6 through 15 of gestation (dg) and killed on dg 18 (mice) or dg 20 (rats).
Subsequently, the uterine contents were evaluated; individual fetal body weights were recorded; and
external, visceral, and skeletal examinations wereperformed. In rats, maternaltoxicity wasobserved inthe
1000-ppm group intheform ofreducedextragestational weightgainand, duringthefirstweekoftreatment,
decreasedbodyweightgain. Undertheseconditions, there was noevidence ofdevelopmentaltoxicity inrats.
In contrast, results of the mouse developmental toxicity study indicated that the fetus may be more
susceptible than the dam to inhaled 1,3-butadiene. Maternal toxicity was observed in mice at the 200- and
1000-ppm 1,3-butadiene exposure levels, whereas 40 ppm and higherconcentrations of1,3-butadiene caused
significant exposure-related reductions in the mean body weights of male fetuses. Mean body weights of
female fetuses were also reduced at the 200- and 1000-ppm exposure levels. No increased incidence of
malformations was observed in either study. Other studies addressing male reproductive and mutagenesis
end points were performed with B6C3F, mice (sperm-head morphology) and Swiss (CD-1) mice (dominant
lethal study). In both studies, groups of20 male mice were exposed to atmospheric concentrations of0, 200,
1000, or 5000 ppm 1,3-butadiene 6 hr/day for 5 consecutive days. There were small concentration-related
increases in abnormal sperm morphology 5 weeks following exposure (the only time of examination).
Sequential postexposure examinations to determine the effect of 1,3-butadiene on all stages of gamete
development were not performed. In the dominant lethal study, there were indications that exposure of
males to levels as low as 200 ppm 1,3-butadiene caused an increase in the percentage offemales with two or
more dead implants in the first week following exposure. In both the first and second weeks following
exposure, there were increases in the number of dead implantations (early), although strict atmospheric
concentration-response relationships were not observed. These results suggest that more mature cells
(spermatozoa and spermatids) might be adversely affected in this strain of mouse.
Introduction
1,3-Butadiene is a colorless, flammable gas that is
produced from ethanol, butane, orbutylene, orby cata-
lytic cracking of light oil or naphtha (1). 1,3-Butadiene
doesnot occurnaturally. Itisusedinthepreparationofa
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variety ofchemicals and is the major component for the
production of synthetic rubber; often in combination
with styrene. 1,3-Butadiene is highly reactive, dimer-
izes to 4-vinylcyclohexene, and polymerizes easily. Be-
cause of this reactivity, inhibitors are added for its
storage and transport. The major manufacturers of
1,3-butadiene in the U.S. produced about 1.5 million
tons in 1980 (2).
Previous toxicity studies indicate that chronic in-
halation exposure to 1,3-butadiene has the potential to
affectthereproductive system. Inachronictoxicityand
carcinogenicity study in rats (3), there was a significant
increase in the incidence ofmammary tumors in femaleMORRISSEY ET AL.
rats and severe kidney toxicity in male rats after 24
months of exposure to 1000 or 8000 ppm of 1,3-bu-
tadiene. In this study, there was an increased incidence
of several different tumor types, including those ofthe
reproductive tract (Leydig cell tumors ofthe testes and
uterine/vaginal stromal tumors). A chronic toxicity and
carcinogenicity studyinwhich mice wereexposedto 625
or 1250ppmof1,3-butadiene wasterminated atabout60
weeks ofexposure because ofhigh mortality associated
with neoplasms at multiple sites, including ovarian
granulosa cell tumors (4). There was also a significant
increase in the incidence of mice with testicular or
ovarian atrophy.
Two reports in the literature present information
regarding the potential of1,3-butadiene to cause repro-
ductive ordevelopmental toxicity inlaboratory animals.
In a reproductive study, male and female rats were
exposed to 600, 2300, or 6700 ppm of1,3-butadiene for8
months (5). A concentration-related depression ofbody
weight was observed. Reproductive studies ofmale and
femaleanimalswereperformed atunstatedtimesduring
these exposures, but no data were given concerningthe
number ofmatings or ofbarren females. The number of
litters from female rats in all exposed groups tended to
be lower than in controls, although litter sizes were
stated to slightly exceed the expected norm of six per
litter. Limited breeding tests of the offspring of the
2300- and 6700-ppm exposure groups suggested that
there was reduced fecundity, but it was not determined
whetherthe deficit was associated with themales orthe
females. Although details were not provided, a small
number ofguinea pigs and rabbits was also used in each
exposure group for reproductive studies. Animals ofall
groups evidently produced progeny, except for rabbits
exposed to 600 and 2300 ppm. The basis forthe authors'
conclusion that any apparent reduction in fertility was
due to hereditary characteristics is not clear.
A teratology study has been reported (6) wherein
female Sprague-Dawley rats were exposed 6 hr per day
to0, 200, 1000, or8000ppmof1,3-butadiene fromdays 6
through 15 ofgestation. There was asignificant concen-
tration-related suppression of maternal body weight
gains during exposure, but body weight gains during
gestation (adjusted for conceptus weight) were signifi-
cantly depressed only in animals exposed to the two
highest concentrations. Reproductive measures (preg-
nancy rate, gravid uterus weight, number of implan-
tation sites, number of fetuses per dam, and pre-
implantation loss) were not affected by 1,3-butadiene
exposure. Mortality of postimplantation embryos
tended to be slightly higher in all groups of exposed
animals than incontrols, butthe difference was statisti-
cally significant only at the highest concentration.
Body weights and crown-rump lengths of fetuses of
the highest exposure group were significantly less than
those of control fetuses (6). There was a significant
increase in minor fetal defects (hematomas and minor
skeletal defects) in all groups, and exposure to 1000 or
8000 ppm resulted in significantly higher incidences of
major skeletal defects. In the 8000-ppm group, there
were significant increases in the incidence of other
anomalies including lens opacities and irregularities of
ossification. Theincidence ofwavyrib, whichwasrarely
observed in historical controls at this laboratory, was
1.6% in the control animals for this study and increased
in a concentration-related manner for exposed animals.
Theauthorsconcluded thatthisresponsewasnotindica-
tive of a teratogenic effect, but was due to maternally
mediated embryonic growth retardation.
The genetic toxicity literature on 1,3-butadiene has
beenrecently reviewed (7). A study usingmale B6C3F1
mice exposed to 6.25, 62.5, or625 ppm 1,3-butadiene for
6 hr/day for 10 days over a 2-week period revealed
significant increases in the frequency of chromosomal
aberrations and sister chromatid exchanges, length-
ening of average generation time, and a depression of
the mitotic index in bone marrow cells (8).
Based on the large volume of production of 1,3-bu-
tadiene andthetoxicity dataavailablethatindicated the
potential of this chemical to affect the development of
the conceptus as well as the structure and function of
reproductive organs, a series of studies was conducted
to evaluate in greater depth the potential of 1,3-bu-
tadiene to cause developmental toxicity in rats and mice
and to cause mutagenic changes in dominant lethal and
sperm-head morphology studies. This paper summar-
izes the results of these four toxicity studies.
Methods and Materials
1,3-Butadiene was obtained from the Phillips Chemi-
cal Company (Borger, TX). For this series of studies,
one lot (F909) of1,3-butadiene was used, theidentity of
which was confirmed by infrared spectroscopy. Gas
chromatograph analysis (2 m x 2 mm Porapak QS
100/120, 100°C isothermal, flameionizationdetector) for
area percent purity of 1,3-butadiene determined the
purity to be 99.88%. Since the rate ofpolymerization of
1,3-butadiene is known to be temperature dependent,
care was takento assure constant storage temperatures
of approximately 72°F. The cylinders of 1,3-butadiene
were never emptied beyond 80% of their volume to
prevent the appearance of high concentration of the
dimer in the 1,3-butadiene atmospheres. Cylinders of
1,3-butadiene were not used ifthe dimer concentration
in the head space exceeded 500 pm.
Animals for these studies were obtained as follows:
Sprague-Dawley rats for the teratology study, B6C3F1
mice for the sperm-head morphology study, and Swiss
(CD-1)miceforthedominantlethalstudy wereobtained
fromthe Charles RiverLaboratory atPortage, MI. The
Swiss (CD-1) mice for the teratology study were ob-
tained from the Charles River Laboratory at Kingston,
NY. These species and strains were selected because of
historical use by the National Toxicology Program
(NTP). Allanimalsweresexuallymaturewhenobtained
and were acclimated to the laboratory for a minimum of
14 days prior to their random assignment to treatment
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Table 1. Experimental design for teratology study of rats and mice exposed to 1,3-butadiene.
Parameter Mice Rats Mice and rats
Chamber concentrations, ppm 0, 40, 200, 1000
Number of sperm-positive females 32, 33, 31, 33 30
per exposure group
Number of days mating (resulting 5
in five exposure subgroups)
Exposure regimen 6-15 dg,a 6 hr/day
Day of sacrifice 18 dg 20 dg
Maternal observations Body weights on 0, 6, Body weights on 0, 6, Signs of toxicity
11, 16, and 18 dg 11, 16, and 20 dg
Lesions at gross necropsy,





Fetal observations Body weight tabulated by
sex; gross, visceral, and
skeletal exams
adg = days of gestation.
groups within studies. Animals were randomized by
weight to minimize potential differences between
groups at the initiation of exposures. All animals were
identified by ear tags and were observed daily through-
out the study forsigns oftoxicity. Animals were housed
in sanitized, stainless-steel, wire-mesh cages. All ani-
mals were fed NIH-07 open formula diet ad libitum
during nonexposure hours. Water was available ad li-
bitum through automatic watering systems. The ani-
mals were maintained underconditions designed to pro-
vide a temperature of72 + 3°F and relative humidity of
50 + 15%. All animals were on a 12-hr light-dark cycle.
Experimental Design
Developmental Toxicity Studies
The design ofthe teratology studies ofrats and mice
exposed to 1,3-butadiene is summarized in Table 1. All
animals for these studies were observed twice daily for
mortality, morbidity, and signs of toxicity. Females
were weighed during the week prior to mating and on
days 0, 6, 11, and 16 ofgestation. On gestation day 18
(mice) or 20 (rats), the animals were killed with CO2,
weighed, and examined for gross tissue abnormalities.
The uterus was removed and weighed; apparent non-
gravid uteri were stained with ammonium sulfide to
detect implantation sites (9). The number, position, and
status of implants were recorded for gravid uteri; pla-
centas were examined and weighed. Live fetuses were
weighed, examined for gross defects, and their sex was
noted. Examinations for fetal lens opacities were con-
ductedbyremovingthe eyelid and examiningthe eye in
situ. In addition, the eyeballs were removed for obser-
vationunderthe dissectingmicroscope. Visceral exami-
nations (10) and skeletal examinations, using specimens
stained with alcian blue and alizarin red (11), were
performed on all live fetuses. Approximately 50% ofthe
fetal heads were examined by razor blade sectioning of
fixed preparations (12).
Table 2. Experimental design for the sperm morphology study
of mice exposed to 1,3-butadiene.
Parameter Specifications
Chamber concentration 0, 200, 1000, and 5000 ppm
Exposure regimen 5 successive days, 6 hr/day
Number of males/group 20
Time of sacrifice During postexposure week 5.
Observations Signs of toxicity
Body weights prior to experimental
treatment and 0, 1, 2, 3, 4, and 5
weeks after treatment
Examination of epididymal preparations
for spermhead abnormalities
Sperm-Head Morphology Assay
The experimental design ofthe sperm-head morphol-
ogy study is summarized in Table 2. The animals in this
study were observed twice daily for mortality, morbid-
ity, and signs oftoxicity;bodyweightsweredetermined
at weekly intervals. During the fifth post-exposure
week, the mice were killed with CO2, weighed, and
examined for lesions of the reproductive tract and for
gross tissue abnormalities. The cauda ofthe right epidi-
dymis was removed and processed to obtain the sperm
suspension. Sperm suspensions were stained with 1%
eosin Y and 2 to 3 drops were transferred to microscope
slides (four slides per mouse). The suspensions were
dried and mounted under coverslips with mounting me-
dium. The evaluation ofspermheads wasdone inablind
manner. The morphology of at least 500 sperm heads
fromeach mouse wascategorized asnormalorabnormal
(blunt hook, banana, amorphous, pinhead, two heads/
two tails, short, and any other type of variants en-
countered during the examination).
Dominant Lethal Study
Thedesignofthedominantlethalstudyissummarized
in Table 3. The animals were observed twice daily for
mortality, morbidity, andsignsoftoxicity;bodyweights
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Table 3. Experimental design for the dominant lethal study
of mice exposed to 1,3-butadiene.
Parameter Specifications
Chamber concentration 70, 200, 1000, and 5000 ppm
Exposure regimen 5 successive days; 6 hr/day
Number ofmales/group Cohabitation of each male with two
females for 1 week; matings for 8
weeks with replacement of two
females each week
Time of sacrifice Females: 12 days after last day of
cohabitation with 1,3-butadiene-
exposed males
Males: after week 8 ofmating
Observations Females: reproductive status; total
number, position, and status of
uterine implants
Males: signs of toxicity-body weights
before experimental treatment and
each week for 8 weeks following
treatment; examination of gross
tissue abnormalities.
ofthe males were determined at weekly intervals. Fol-
lowing the eighth week of cohabitation with groups of
untreated females, male mice were killed with CO2,
weighed, and examined for lesions of the reproductive
tract and gross tissue abnormalities. Female mice were
killedwith CO2 12daysafterthelastdayofcohabitation.
Thereproductive status was determined and the gravid
uterus was removed to determine the total number,
position, and status of implantations. The numbers of
earlyandlateresorptions and live anddead fetuses were
determined.
Inhalation Exposures
All animals were exposed to the test atmospheres
within Hazelton 2.3 m3 stainless-steel inhalation cham-
bers. Animals were exposed in individual cages
equipped with feed troughs and automatic watering
devices. During exposure, the feed troughs were re-
moved from each cage unit. Water was available ad
libitum at all times.
For generation of chamber atmospheres, 1,3-bu-
tadiene was withdrawn directly from a gas cylinder and
diluted with filtered air. An air-driven vacuum pump
delivered the 1,3-butadiene-air mixture to the exposure
chamber inlet for final dilution to the desired con-
centration.
The concentration of 1,3-butadiene in the chambers
was monitored using an HP 5840 gas chromatograph
equipped with a flame ionization detector (oven, 120°C;
1/8 x 12"nickel column packedwith 1% SP-1000 on 60/80
mesh Carbopack B). The mean daily concentration of
1,3-butadiene in the chambers during these studies
neverdeviated fromtheintendedconcentration by more
than 10%. The highest relative standard deviation for
any one ofthe exposure groupsduringthese studies was
3%. Thus, because ofthe extreme closeness ofthe ana-
lyzed concentration to the intended nominal con-
centrations, reference throughout this paper is made
only to the nominal concentrations.
Statistical Evaluation
In the teratology studies, analysis of variance was
used to analyze weight data and, if the result of the
analysis was significant, Duncan's multiple range test
was performed to delineate intergroup differences. Re-
sponse proportions such as the number of resorptions;
implants; and live, dead, or affected fetuses per litter
were also analyzed by an analysis ofvariance following
arcsin transformation of the response proportion.
Binary-response variables between groups was com-
pared, using chi-square or Fisher's exact test (13), e.g,
numbers ofpregnant females per number inseminated.
Inthe dominantlethalstudy, thenumberofimplanta-
tion sites and intrauterine deaths per litter for each
week were analyzed by analysis ofvariance. When ap-
propriate, proportions of resorptions and dead or live
fetusesperimplantweresubjectedtoanarcsintransfor-
mation and evaluated by analysis of variance. If the
analysis ofvariance F statisticwassignificant, Duncan's
multiple range test was used to delineate intergroup
differences.
In the sperm-head morphology study, values for nor-
mal and abnormal sperm heads were expressed as a
percentageofthetotalnumberofcellsexaminedforeach
animal. These data were subjected to an arcsin trans-
formation and evaluated by an analysis of variance. If
the analysis ofvariance F statistic was significant, Dun-
can's multiple range test was used to delineate inter-
group differences. Dose response trends were deter-
mined by means of orthogonal contrast (14).
Results
Developmental Toxicity Studies
In the rat study, the only toxicity observed was in
dams at the 1000 ppm exposure level (15). There was a
decrease in maternal body weight gain between days 6
and 11 of gestation (dg) and a decrease in extra-
gestationalbodyweightgain (dambodyweight ondg20
minus weight of the gravid uterus). The percentage of
pregnantanimals and numberoflitters withlive fetuses
were unaffected by treatment. Similarly, there were no
significant differences among exposure groups with re-
spect to number of live fetuses per litter, percentage
resorptions or percentage malformations per litter,
placental or fetal body weights, or sex ratio.
In the mouse study, measures of maternal toxicity
were adverselyaffected by 1,3-butadiene exposure dur-
ingpregnancy (16) (Table 4). As inthe rat study, extra-
gestationalweightgainwasreduced, butinthisstudyit
was also reduced at 200 ppm as well as 1000 ppm.
Maternal body weight gain from dg 11 to 16 was also
adverselyaffected atthese exposurelevels. Inaddition,
maternal body weight on dg 18 and gravid uterine
weight were, reduced in the 1000-ppm group relative to
the control group. Maternal body weight gain was not
reduced during other periods of gestation. Fetal and
placental weights were reduced in an exposure-related
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Table4. Maternal anddevelopmental toxicityinSwiss(CD-1)mice
resulting from exposure to 1,3-butadiene.
Atmospheric concentration
of 1,3-butadiene, ppm
Parameter 40 200 1000
Maternal body weight, 18 dg 4'a
Maternal weight gain, 11-16 dg 4' 4'
Extragestational weight gainb ' 4'
Gravid uterine weight 4'
Fetal body weight 1 4'
Females 4' 4
Males 4 4' 4
Placenta weight 4' 4'
Females 4
Males 4' 4'
aArrows denote a statistically significant (p S 0.05) decrease com-
pared with the control group value.
bWeight gain of the dam corrected for the weight of the gravid
uterus.
manner. At 40 ppm, mean male fetus body weight was
reduced to 95% ofthe control value. A similar decrease
in female fetus body weight was not statistically signifi-
cant at this level, but values for both male and female
fetalbodyweights weresignificantly reduced atthe200-
and 1000-ppm 1,3-butadiene levels. Placenta weights of
male and female fetuses were reduced at the 1000-ppm
1,3-butadiene concentration, butonlyplacentaweightof
male fetuses was reduced at 200 ppm 1,3-butadiene.
There were no significant differences in percentage re-
sorptions or percentage malformations per litter, al-
though increases in fetal variations (supernumary ribs,
reduced ossification of sternebrae) were observed at
exposure levels of 200 and 1000 ppm.
Sperm-Head Morphology Assay
There was no mortality as a result of treatment of
male B6C3F1 mice at 200, 1000, or 5000 ppm for 5
consecutivedays(17). Transienttoxicsigns(piloerection
and dyspnea) were observed for 20 to 30 min following
exposureto5000ppm1,3-butadiene. Meanbodyweights
of 1,3-butadiene-exposed groups were not significantly
different from the control value. There were con-
centration-related small increases in the percentage of
abnormalspermheadsatthe 1000-and5000-ppm1,3-bu-
tadiene levels at 5 weeks after treatment (other time
points were notevaluated). There was a21% increasein
abnormal sperm at 200 ppm (not statistically signifi-
cant), 73% at 1000, and 129% at 5000 ppm. The back-
ground incidence ofabnormalsperminthecontrolgroup
(1.6%) is consistent with the NTP historical control
value (1.7%) for this strain of mouse.
Dominant Lethal Study
There was no mortality with CD-1 mice using con-
centrations of 1,3-butadiene up to 5000 ppm for 5 con-
secutive days (18). Transient toxic signs were similar to
those in the sperm-head morphology assay, and body
weights were unaffected by treatment.
Table 5. Results ofdominant lethal study in Swiss (CD-1) mice
exposed to 1,3-butadiene for 5 consecutive days.
Atmospheric concentration
of 1,3-butadiene, ppm
Parameter 200 1000 5000
Week 1
Dead implants/total implants, % ta
Females with 2 2 dead implants, % t 1




No. dead implants/pregnancy t
Early 1
Late
aArrows denote a statistically significant (p< 0.05) increase com-
paredwiththecontrolgroupvalue. Theabsenceofanarrowdenotesno
difference from control.
Week 1. At 1000 ppm (week 1 following exposure)
therewasasignificantincreaseinthepercentageofdead
implants expressed as a function oftotal implantations
(Table 5). There were smaller increases at 200 and 5000
ppm that were not statistically significant compared
with the control group. Ofthe female mice mated with
exposed males, there were significant increases (ap-
proximately 3-fold) in the percentage of females with
two or more dead implantations in all 1,3-butadiene-
mated groups. The number of dead implantations per
pregnancy was increased only in the 1000-ppm group.
Week2. Duringthe second week following exposure,
the number of dead implantations per pregnancy was
increased inboth the200- and 1000-ppmgroups, butnot
in the 5000-ppm 1,3-butadiene group. No significant
increases in the end points evaluated were observed in
weeks 3 to 8. While not strongly concentration-
dependent, these results are consistent with an adverse
effect of 1,3-butadiene on more mature cells (sperma-
tozoa and spermatids).
Discussion
The lack ofdevelopmental toxicity in the current rat
studyisincontrasttotheresultsofapriorstudy(6)that
reported an increase in major skeletal defects (as a
percentage of the fetuses evaluated) in the 1000- and
8000-ppm 1,3-butadiene exposure groups. The values
are similar if expressed as percentage skeletal malfor-
mations per litter (0.6, 2.5, 2.8, and 6.0%, control, 200,
1000, 8000 ppm levels, respectively). Both studies de-
tected a decrease in extragestational weight gain of
dams exposed to 1000 ppm 1,3-butadiene. The earlier
study also detected a concentration-related decrease in
maternal weight gain during the exposure period that
extendedtothe200-ppmgroup(thelowestleveltested);
no similar decrease was observed at the 40- or 200-ppm
levelsinthecurrentstudy. Thebasisforthediscrepancy
in maternal and embryo-fetal effects is not known.
Although developmental toxicity was not observed in
the present rat study, there may be reason for concern
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for the developing organism based on results of the
mouse study reported here. In this study, maternal
toxicity was observed at the 200- and 1000-ppm 1,3-bu-
tadiene levels, whereas developmental toxicity in the
form ofreduced male fetal body weight was present at
the lowest level tested, 40 ppm 1,3-butadiene. Since
developmentaltoxicity, whichcanbemanifested asmal-
formation, intrauterine death, decreased body weight,
or functional deficits, may be expressed in different
waysindifferentspecies, thedecreaseinmalefetalbody
weight, particularly inthe absence ofmaternal toxicity,
may be of concern considering that the Occupational
Safety and Health Association (OSHA) standard for
1,3-butadiene is currently 1000 ppm.
Thus, no developmental toxicity was seen in rats at
any ofthe concentrations tested, eveninthe presence of
maternal toxicity (1000 ppm). These studies showed
developmental toxicity in mice in the presence of ma-
ternal toxicity (200 and 1000 ppm 1,3-butadiene) and
decreased fetal body weight in the absence ofmaternal
toxicity (40 ppm). Sperm-head morphology and domi-
nant lethal studies in mice given concentrations of
1,3-butadiene between 200 and 5000 ppm showed re-
sponses that may be indicative of weak germ cell mu-
tagenic activity. The possibility of germ cell effects is
supported by clear evidence ofgenotoxicity in somatic
cells, as indicatedby significant increases in sisterchro-
matid exchange at a concentration of 6 ppm 1,3-bu-
tadiene, as well as by other genotoxicity assays (8).
We thank Louise Oyster and Judy Bullard for expert secretarial
assistance.
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